CDK9 Antikörper (C-Term)
Kurzübersicht für CDK9 Antikörper (C-Term) (ABIN6391359)
Target
Alle CDK9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- CDK9
-
Sequenz
- KGSQITQQST NQSRN
-
Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Schwein, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 40-45 kDa band observed in nuclear cell lysates of NIH3T3 (calculated MW of 42.8 kDa according to Mouse NP_570930.1). Recommended concentration: 0.3-1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:8000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
-
Andere Bezeichnung
- CDK9
-
Hintergrund
- CDK9, cyclin-dependent kinase 9, C-2k, CDC2L4, CTK1, PITALRE, TAK, CDC2-related kinase, cell division cycle 2-like protein kinase 4, cell division protein kinase 9, serine/threonine protein kinase PITALRE, tat-associated kinase complex catalytic subunit
-
Gen-ID
- 1025, 107951, 362110
-
NCBI Accession
- NP_001252
-
Pathways
- Zellzyklus
Target
-